Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Laba Operasional
Harga Saham
87.37
Perubahan Harian
0.89
1.03%
Bulanan
-10.61%
Tahunan
-22.47%
Q1 Perkiraan
82.99
Keuangan
Harga Saham
USD
Aktiva
USD 12.17B
Kas Dan Setara
USD 919.86M
Biaya Penjualan
USD 350.4M
Aset Lancar
USD 2.24B
Kewajiban Lancar
USD 1.33B
UTANG
USD 3.37B
Dividen - Hasil
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.7
Modal Dan Cadangan
USD 7.38B
Laba Kotor Pada Penjualan
USD 421.66M
Beban Bunga Utang
USD 23.51M
Pendapatan Bunga
USD 0.4
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 10.94B
Batas Pemasukan
USD 98.36M
Biaya Operasional
USD 626.22M
Laba Operasional
USD 145.83M
Modal Saham Biasa
USD 113.38M
Pe Harga Untuk Laba
49.87
Laba Sebelum Pajak
USD 55.68M
Pendapatan Penjualan
USD 772.06M
Beban Penjualan Dan Administrasi
USD 251.73M
Saham
USD 379.5M
Kreditur Perdagangan
USD 185.46M
Debitur Perdagangan
USD 744.67M
Laba Operasional
Perubahan
Tanggal
Agilent
USD 353M
90M
2025-12
Align Technology
USD 224.71M
40.06M
2025-12
Bio Techne
USD 54.46M
6.8M
2025-12
Bio-Rad Laboratories
USD 63.9M
13.2M
2025-09
Bruker
USD 76.3M
7.6M
2025-12
Celltrion
KRW 301.04B
58.57B
2025-09
Charles River Laboratories
USD 75.82M
57.98M
2025-12
Cspc Pharmaceutical
CNY 1.22B
60.54M
2025-09
Danaher
USD 1.5B
348M
2025-12
Dentsply International
USD 538M
26M
2025-12
Deva Holding AS
TRY 964.87M
240.32M
2023-09
Dianthus Therapeutics
USD -40.29M
5.36M
2025-09
Divis Laboratories Ltd
INR 7.72B
30M
2025-12
Edwards Lifesciences
USD 370.3M
54.8M
2025-12
Exact Sciences
USD -25M
22.85M
2025-09
Hologic
USD 237M
16M
2025-12
Illumina
USD 256M
6M
2025-12
Intuitive Surgical
USD 865.3M
97.5M
2025-12
IQVIA Holdings
USD 2.68B
2.1B
2025-12
Kangmei Pharma
CNY -26.7M
43.13M
2025-09
Knight Therapeutics
CAD 2.94M
2.4M
2025-09
Laboratorios Farma
EUR 135.05M
49.84M
2023-12
Laboratory Of America
USD 382M
15.3M
2025-12
Malin Corporation
EUR -1.1M
400K
2024-12
Medical Developments International
AUD -36K
444K
2025-12
Mesa Laboratories
USD 5.78M
2.27M
2024-12
Mettler Toledo International
USD 351.93M
57.73M
2025-12
Myriad Genetics
USD -23.3M
10.8M
2025-09
Neuren Pharmaceuticals
AUD 17.01M
11.56M
2025-12
OraSure Technologies
USD -13.59M
2.13M
2025-12
Organigram Holdings
CAD -28.05M
7.76M
2025-09
Ovoca Bio
EUR -5.65M
3.45M
2022-06
Pacific Biosciences Of California
USD -53.19M
35.08M
2025-12
Pharma Mar
EUR 43.61M
47.57M
2025-12
Qiagen NV
USD 121.88M
15.41M
2025-12
Quest Diagnostics
USD 386M
0
2025-12
Quidel
USD -37.3M
667.5M
2025-12
Repligen
USD 19.97M
7.29M
2025-12
Revvity
USD 145.83M
47.49M
2025-12
Sartorius
EUR 150.1M
11.7M
2025-09
Sino Biopharmaceutical
CNY 5.18B
3.32B
2025-06
Thermo Fisher Scientific
USD 2.3B
226M
2025-12
Tilray
USD -20.01M
9.34M
2025-09
Waters
USD 270.52M
78.4M
2025-12
Zz Pientze Pharmaceu
CNY 501.33M
52.54M
2025-09